je.st
news
Tag: drug
AstraZeneca cancer drug, companion test approved
2014-12-19 21:03:21| Biotech - Topix.net
U.S. regulators on Friday granted accelerated approval to the first in a new class of targeted drugs for ovarian cancer, Lynparza from British drugmaker AstraZeneca PLC . The drug is for women whose ovarian cancer is associated with certain defective genes and whose cancer persists after multiple treatments.
Tags: test
approved
drug
cancer
Merck buys Swiss biotech with promising cancer drug
2014-12-18 19:05:10| Biotech - Topix.net
Drugmaker Merck says it's bought a Swiss biotech company developing cancer drugs as part of its strategy to be a top player in cancer, one of the hottest pharmaceutical research areas. Merck & Co., based in Kenilworth, New Jersey, will pay up to $110 million upfront to OncoEthix.
Tags: drug
cancer
swiss
promising
Merck Buys Swiss Biotech With Promising Cancer Drug
2014-12-18 19:05:09| Biotech - Topix.net
Drugmaker Merck says it's bought a Swiss biotech company developing cancer drugs as part of its strategy to be a top player in cancer, one of the hottest pharmaceutical research areas. Merck & Co., based in Kenilworth, New Jersey, will pay up to $110 million upfront to OncoEthix.
Tags: drug
cancer
swiss
promising
Exclusive: Amgen's new leukemia drug to carry $178,000 price tag
2014-12-17 23:05:29| Biotech - Topix.net
Amgen Inc on Wednesday said its new type of treatment for a deadly form of leukemia would cost about $178,000 when it becomes available on Thursday, which would make it one of the world's most expensive cancer drugs. Company spokeswoman Danielle Bertrand said the price for the infused medicine, called Blincyto, would reflect two courses of treatment, at $89,000 per cycle.
Investigational drug increases PFS in patients with advanced breast cancer
2014-12-17 14:34:20| Biotech - Topix.net
In a groundbreaking study that offers new hope for women with advanced breast cancer, researchers from UCLA's Jonsson Comprehensive Cancer Center have published final clinical trial results that showed the amount of time patients were on treatment without their cancer worsening was effectively doubled in women with advanced breast cancer who took the experimental drug palbociclib. An investigational drug discovered and being developed by Pfizer Inc., palbociclib targets a key family of proteins responsible for cell growth by preventing them from dividing.
Tags: advanced
drug
cancer
increases
Sites : [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] next »